Baebies Stock
Newborn Screening and Pediatric Testing
Sign up today and learn more about Baebies Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Baebies Stock
Baebies was founded in 2014 by Richard West and Vamsee Pamula, following the successful development of digital microfluidics technology, the development and launch of multiple products, and the eventual sale of Advanced Liquid Logic to Illumina, Inc. Baebies has now licensed its core technology, acquired product and manufacturing assets, and built a seasoned management and technical team to pursue opportunities in newborn screening and pediatric testing. The Baebies mission is to save lives and make lives better for millions of children by bringing new technologies, new tests and new hope to parents and healthcare professionals worldwide.
Investors
Funding History
June 2015 | $13.0M |
---|---|
July 2015 | $500K |
November 2016 | $18.8M |
February 2017 | $5.0M |
February 2018 | $12.8M |
July 2019 | $6.0M |
February 2021 | $56K |
April 2021 | $11.6M |
May 2021 | $2.7M |
Management
Chief Executive Officer
Richard West
Chief Financial Officer
Lucy Martindale
Press
patents - Apr, 15 2024
Digital microfluidics multi-dynamic range parallel biochemical assayspatents - Apr, 15 2024
Micro-regional thermal control for digital microfluidicspatents - Apr, 15 2024
Coagulation assays for a point-of-care platformpatents - Apr, 15 2024
Digital microfluidics (dmf) system, cartridge, and methods for thermal …patents - Apr, 15 2024
Coagulation assays for a point-of-care platform